WallStSmart

Spectral AI Inc. (MDAI)vsMedtronic PLC (MDT)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Medtronic PLC generates 209443% more annual revenue ($35.48B vs $16.93M). MDT leads profitability with a 13.0% profit margin vs -82.0%. MDT earns a higher WallStSmart Score of 61/100 (C+).

MDAI

Avoid

17

out of 100

Grade: F

Growth: 2.7Profit: 2.0Value: 4.7Quality: 5.0
Piotroski: 4/9Altman Z: -4.12

MDT

Buy

61

out of 100

Grade: C+

Growth: 4.7Profit: 6.5Value: 6.0Quality: 4.8
Piotroski: 2/9
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

MDAIFair Value (-2.7%)

Margin of Safety

-2.7%

Fair Value

$1.50

Current Price

$1.89

$0.39 premium

UndervaluedFair: $1.50Overvalued
MDTUndervalued (+10.3%)

Margin of Safety

+10.3%

Fair Value

$89.60

Current Price

$81.67

$7.93 discount

UndervaluedFair: $89.60Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

MDAI1 strengths · Avg: 10.0/10
Debt/EquityHealth
-1.1310/10

Conservative balance sheet, low leverage

MDT4 strengths · Avg: 8.3/10
Market CapQuality
$94.69B9/10

Large-cap with strong market position

Price/BookValuation
2.1x8/10

Reasonable price relative to book value

Operating MarginProfitability
20.0%8/10

Strong operational efficiency at 20.0%

Free Cash FlowQuality
$2.08B8/10

Generating 2.1B in free cash flow

Areas to Watch

MDAI4 concerns · Avg: 2.8/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$64.60M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-2308.0%2/10

ROE of -2308.0% — below average capital efficiency

Revenue GrowthGrowth
-40.5%2/10

Revenue declined 40.5%

MDT2 concerns · Avg: 2.5/10
Piotroski F-ScoreQuality
2/93/10

Weak financial health signals

EPS GrowthGrowth
-11.8%2/10

Earnings declined 11.8%

Comparative Analysis Report

WallStSmart Research

Bull Case : MDAI

The strongest argument for MDAI centers on Debt/Equity.

Bull Case : MDT

The strongest argument for MDT centers on Market Cap, Price/Book, Operating Margin. PEG of 1.29 suggests the stock is reasonably priced for its growth.

Bear Case : MDAI

The primary concerns for MDAI are EPS Growth, Market Cap, Return on Equity.

Bear Case : MDT

The primary concerns for MDT are Piotroski F-Score, EPS Growth.

Key Dynamics to Monitor

MDAI profiles as a turnaround stock while MDT is a value play — different risk/reward profiles.

MDAI carries more volatility with a beta of 1.16 — expect wider price swings.

MDT is growing revenue faster at 8.7% — sustainability is the question.

MDT generates stronger free cash flow (2.1B), providing more financial flexibility.

Bottom Line

MDT scores higher overall (61/100 vs 17/100). Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Spectral AI Inc.

HEALTHCARE · MEDICAL DEVICES · USA

Spectral MD Holdings, Ltd., a predictive analytics company, develops AI algorithms and optical technology in wound care treatment. The company is headquartered in Dallas, Texas.

Medtronic PLC

HEALTHCARE · MEDICAL DEVICES · USA

Medtronic plc is an American-Irish registered medical device company that primarily operates in the United States. Medtronic has an operational and executive headquarters in Fridley, Minnesota in the US.

Want to dig deeper into these stocks?